In brain samples from AD subjects as well as in three mouse models with AD-like pathology, PDK1 overactivity was also shown to contribute to the accumulation of Aβ40/42 peptides and the progression of AD by cancelling the non-amyloidogenic processing of APP by TACE [24]. This evidence concerns the gene APP and Alzheimer disease.